In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody

Acta Neuropathol. 2014 Dec;128(6):893-5. doi: 10.1007/s00401-014-1364-1. Epub 2014 Nov 7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Amyloid beta-Peptides / cerebrospinal fluid
  • Autoantibodies / blood*
  • Biomarkers / blood
  • Biomarkers / cerebrospinal fluid
  • Female
  • Humans
  • Lewy Body Disease / blood*
  • Lewy Body Disease / cerebrospinal fluid
  • Lewy Body Disease / diagnosis
  • Male
  • Parkinson Disease / blood*
  • Parkinson Disease / cerebrospinal fluid
  • Parkinson Disease / diagnosis
  • Peptide Fragments / cerebrospinal fluid
  • Severity of Illness Index
  • alpha-Synuclein / blood*
  • tau Proteins / cerebrospinal fluid

Substances

  • Amyloid beta-Peptides
  • Autoantibodies
  • Biomarkers
  • MAPT protein, human
  • Peptide Fragments
  • SNCA protein, human
  • alpha-Synuclein
  • amyloid beta-protein (1-42)
  • tau Proteins